[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Social media discussions focus on the $9.31B allocated for ICE operations, with critics demanding transparency. Engagements are down significantly over the past month.
This topic appears to be related to social media discussion around the $9.31B allocated for ICE operations.
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Month: XXXXXX -XX%
1-Year High: XXXXXXX on 2025-06-02
1-Year Low: X on 2025-05-16
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +400%
1 Month: XX +11%
1-Year High: XX on 2025-04-30
1-Year Low: X on 2025-04-28
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $931b in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X +300%
1 Month: X +13%
1-Year High: XX on 2025-04-30
1-Year Low: X on 2025-04-28
Top topics mentioned In the posts about $931b in the last XX hours
$179b, italy, $180b, $205b, france, $927b, $913b, $936b, $932b
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Biggest Shadow (Informal Market) Economies: China: $3.6T United States: $1.4T India: $931B Brazil: $448B Indonesia: $326B Mexico: $320B Germany: $308B Japan: $282B Russia: $265B France: $205B Trkiye: $180B Italy: $180B UK: $179B Note: 2023 data Source: EY Global Shadow Economy Report"
@statsglobe on X 2025-07-18 14:41:11 UTC 4278 followers, XXX engagements
"$JNJ Johnson & Johnson Q225 Earnings Highlights 🔹 Revenue: $23.74B (Est. $22.86B) 🟢; +5.8% YoY 🔹 Adj. EPS: $XXXX (Est. $2.68) 🟢; -XXX% YoY FY25 Guidance 🔹 Reported Sales: $93.2B$93.6B (Est. $91.3B) 🟢 🔹 Adj. EPS: $10.63$10.73 (Est. $10.61) 🟢; +7.0% YoY 🔹 Adj. Oper Revenue Growth: +3.2% to +3.7% (Prior: +2.0% to +3.0%) 🔹 Operational Sales: $92.7B$93.1B (Prior: $91.6B$92.4B) Segment Revenue 🔹 Innovative Medicine: +2.4% YoY 🔹 MedTech: +4.1% YoY Regional Revenue (Adjusted Operational) 🔹 U.S.: +5.0% YoY 🔹 International: +0.4% YoY Other Q2 Metrics: 🔹 Net Income: $5.54B; +18.2% YoY 🔹"
@wallstengine on X 2025-07-16 10:25:29 UTC 72.5K followers, 12.2K engagements